Waverley Pharma Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Vol. 1Y

—

Shs. 5Y

—

Rev. 5Y

129.62%

Div Yld LY

—

Div Yld TTM

—

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.

Key people

Larry Thiessen

President, Chief Executive Officer, Director · since 2023

Haaris Uddin

Chief Financial Officer · since 2020

Albert Friesen

Chairman of the Board · since 2016

P. Marcus Enns

Independent Director · since 2016

James Kinley

Independent Director · since 2024

URL

https://www.waverleypharma.com/

IPO date

Apr 27, 2017

Employees

Domiciled in

Incorporated in

Legal address

C/O Pushor Mitchell LLP
301 - 1665 Ellis Street
Kelowna, BC V1Y 2B3
CA

Headquarters

4-1250 Waverley Street
Winnipeg, MB R3T 6C6
CA

Valuation

No data to show